These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 314657)

  • 1. Lymphokines and thrombosis. Thrombocyte and coagulation activation by culture supernatants of concanavalin-A-stimulated human lymphocytes. Some physicochemical properties and inhibition by chemical compounds.
    Coeugniet E
    Scand J Haematol Suppl; 1979; 34():90-102. PubMed ID: 314657
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphokines and thrombosis. I. Thrombocyte aggregating activity released by human lymphocytes stimulated with concanavalin-A.
    Coeugniet E; Bendixen G
    Acta Allergol; 1976 Apr; 31(2):94-106. PubMed ID: 947142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombocyte migration inhibitory activity of human lymphocytes stimulated with concanavalin-A antagonized by dipyridamole and acetylsalicylic-acid.
    Coeugniet E
    Thromb Haemost; 1978 Apr; 39(2):528-9. PubMed ID: 581000
    [No Abstract]   [Full Text] [Related]  

  • 4. Human leucocyte response to migration inhibitory activity from lymphocytes. Modification by aprotinin, Tranexamic acid and phenylmethyl sulfonylfluoride.
    Coeugniet E; Søeberg B; Bendixen G
    Acta Med Scand; 1978; 203(3):191-5. PubMed ID: 305717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombocyte migration inhibitory activity of concanavalin-A-stimulated human lymphocytes. In vivo and in vitro modifications by dipyridamole and acetylsalicylic acid.
    Coeugniet E
    Thromb Res; 1979; 15(3-4):297-307. PubMed ID: 386557
    [No Abstract]   [Full Text] [Related]  

  • 6. Lymphokines and thrombosis. II. Procoagulant activity produced by human lymphocytes stimulated with concanavalin A (con-A).
    Coeugniet E; Bendixen G
    Acta Allergol; 1976 Apr; 31(2):107-15. PubMed ID: 947136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet therapy (first of two parts).
    Weiss HJ
    N Engl J Med; 1978 Jun; 298(24):1344-7. PubMed ID: 651993
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of drugs of platelets and complications of vascular disease.
    Mustard JF; Packham MA; Kinlough-Rathbone RL
    Adv Exp Med Biol; 1977; 82():94-105. PubMed ID: 920448
    [No Abstract]   [Full Text] [Related]  

  • 9. Dipyridamole alone or combined with low-dose acetylsalicylic acid inhibits platelet aggregation in human whole blood ex vivo.
    Müller TH; Su CA; Weisenberger H; Brickl R; Nehmiz G; Eisert WG
    Br J Clin Pharmacol; 1990 Aug; 30(2):179-86. PubMed ID: 2206782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of varying doses of dipyridamole and acetyl salicylic acid on the inhibition of platelet functions and their effect on bleeding time.
    Rajah SM; Penny AF; Crow MJ; Pepper MD; Watson DA
    Br J Clin Pharmacol; 1979 Nov; 8(5):483-9. PubMed ID: 508556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological investigation of substances affecting platelet function.
    Smith GM
    Acta Cardiol; 1974; Suppl 19():95-102. PubMed ID: 4548299
    [No Abstract]   [Full Text] [Related]  

  • 12. Dipyridamole potentiates the inhibition of platelet aggregation by aspirin (in human platelet rich plasma and whole blood).
    Violi F; Praticò D; Iuliano L; Balsano F
    J Lipid Mediat; 1991; 4(1):61-7. PubMed ID: 1909906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of aspirin and dipyridamole on the interaction of human platelets with sub-endothelium: studies using citrated and native blood.
    Weiss HJ; Turitto VT; Vicic WJ; Baumgartner HR
    Thromb Haemost; 1981 Apr; 45(2):136-41. PubMed ID: 7256696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of thrombosis by thrombocyte inhibitors. 1. Cell regulation mechanisms and pharmacological modification].
    Hansen MS; Birgens HS
    Ugeskr Laeger; 1980 Jan; 142(5):303-5. PubMed ID: 6243811
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevention of thrombosis using aspirin? nfluence of acetylsalicylic acid on thrombocyte aggregation in vitro and in vivo].
    Scharrer I; Schepping M; Breddin K
    Klin Wochenschr; 1969 Dec; 47(24):1318-24. PubMed ID: 5382021
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of acetylsalicylic acid and aprotinin on the platelet function and coagulation of preserved blood].
    Haas-Denk S; Kaunzner W; von Sommoggy S
    Med Welt; 1977 May; 28(19):912-4. PubMed ID: 301977
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter: Intervention of dipyridamole and acetylsalicylic acid in the development of thrombosis in cell-mediated immune reactions: possible mechanism of action.
    Coeugniet E
    Thromb Diath Haemorrh; 1975 Dec; 34(3):861-3. PubMed ID: 1209550
    [No Abstract]   [Full Text] [Related]  

  • 18. Leucocyte migration inhibitory activity of concanavalin-A-stimulated human lymphocytes. Modification by dipyridamole, lysine-acetylsalicylate and heparin.
    Coeugniet E; Bendtzen K; Bendixen G
    Acta Med Scand; 1976; 199(1-2):99-104. PubMed ID: 1251778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of acetylsalicylic acid and dipyridamole on platelet survival and aggregation in patients with atherosclerosis obliterans.
    Abrahamsen AF; Eika C; Godal HC; Lorentsen E
    Scand J Haematol; 1974; 13(4):241-5. PubMed ID: 4614427
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction of platelets with subendothelium in humans treated with aspirin and dipyridamole alone or in combination.
    Escolar G; Bastida E; Ordinas A; Castillo R
    Thromb Res; 1985 Nov; 40(3):419-24. PubMed ID: 4082117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.